Barron's
Obesity drugs Ozempic and Wegovy are upending the health care system. Should we be concerned?
Novo Nordisk and Eli Lilly are about to start raking in tens of billions of dollars a year on their new obesity drugs, ...
CRISPR’s biggest challenge is addressing complex hereditary ailments like cystic fibrosis — but progress is being made
Treatments based on the Nobel-prize winning Crispr gene-editing approach can make permanent changes to a genetic flaw— but those edits ...
Gene transfer therapies are the ‘next big thing’ in medicine. Here’s how gene editing works and the companies behind it
The breakthroughs made possible by gene editing were shown in the Jan. 6 news that base editing had repaired a ...
Why gene therapy’s potential is attracting intense interest from Big Pharma
Big Pharma has been struggling for years to produce drugs that are major breakthroughs in medicine. For these companies, gene ...
